Amy Berger

Amy Berger, MD, PhD serves as a Volunteer Assistant Clinical Professor at the University of California, San Francisco School of Medicine, functioning as a physician-scientist at the intersection of clinical medicine and translational research.

Her educational background includes:

• MD, PhD in Neuroscience (2012) - University of California, San Francisco
• BS in Biological Sciences (2002) - Stanford University
• Residency in Internal Medicine (2016) - UCSF
• Fellowships in Academic Hospital Medicine and Clinical and Translational Science (2017) - UCSF

Berger's research program focuses on physician-scientist training pathways, pathophysiology-based clinical reasoning, and translating emerging technologies to clinical practice. Her work integrates molecular neuroscience with patient care, particularly in neurology and genetics. Current investigations examine neurodegenerative biomarkers, epilepsy genetics, and metagenomic diagnostic applications.

Analysis of her publication record (2008-2024) reveals sustained contributions to translational neuroscience with emphasis on neurogenetics and clinical diagnostics. Her collaborative work spans epilepsy pathology, frontotemporal dementia biomarkers, and metagenomic sequencing for infectious diseases, demonstrating consistent engagement with cutting-edge molecular techniques applied to neurological disorders.

Berger actively contributes to physician-scientist development through the Molecular Medicine Investigation Unit at UCSF, focusing on integrated clinical research training models. Her work on opioid receptor trafficking mechanisms represents foundational contributions to addiction pharmacology earlier in her career.